Overview of stone management in Japan

Preview:

DESCRIPTION

Overview of stone management in Japan. The 10 th Catholic International Urology Symposium, 2008 14 June 2008 Catholic University, Seoul. Tetsuro Matsumoto, MD, PhD Department of Urology, University of Occupational and Environmental Health. Incidence and management of stone - PowerPoint PPT Presentation

Citation preview

UOEH   urology

Overview of stone management in Japan

Tetsuro Matsumoto, MD, PhDDepartment of Urology, University of

Occupational and Environmental Health

The 10th Catholic International Urology Symposium, 200814 June 2008Catholic University, Seoul

UOEH   urology

Incidence and management of stone diseases in Japan

Incidence rate of urinary stone in Japan( /100,000 population )

119.640.379.3Female

308.9116.9192.0Male

Incidence rate

(/year)Reccurence

First diagnosis

UOEH   urology

2005

Incidence rate in whole life (Incidence/year x average life expectancy x 100)

1995

  Male :  122.6/100,000×76.36×100= 9.4%

  Female :  49.4/100,000×82.84×100= 4.1%

2005

  Male :  192.0/100,000×78.53×100=15.1%

  Female :  79.3/100,000×85.49×100= 6.8%

UOEH   urology

Incidence rate of upper urinary tract stoneIncidence (/100,000)

Incidence after demographycal correction

MaleFemale Total

MaleFemale Total

UOEH   urology

Chronological change of incidence rate classified by age

Male

Female

UOEH   urology

(Every 10 years)

Incidence of upper urinary stone classified by age(First diagnosis/Recurrence)

(/100,000)

Male firstFemale firstMale recurrenceFemale recurrence

MaleFemale

First:Recurrence

UOEH   urology

Constituent of upper urinary tract stone in Japam

Male Female

Ca stone

2005

Infection stone

Urate stone

Cystine

Others

Ca stone

Infection stone

Urate stone

Cystine

Others

UOEH   urology

Male Female

Ca stone

Infection stone

Urate stone

Cystine

Ca stone

Infection stone

Urate stone

Cystine

2005

Constituent of lower urinary tract stone in Japan

UOEH   urology

Chronological change of constituent of upper urinary tract stone classified by age

Male

Female

Ca stone

Struvite

UrateCystine

Others

UOEH   urology

Past history and basic disease in patients          Rate (%)

Family history    9.7

Hypertension    21.7

Diabetes       9.8

Hyperlipidemia   14.1

Osteoporosis    2.0

    Rate (%)

Hyperuricemia

Hypercalciuria

Hyperuricuria

Hyperoxaluria

Hypocitruria

13.7

3.1

3.2

1.5

2.0

Basic disease

UOEH   urology

History

2005

Management of stone diseases in Japan

ESWL only TUL onlyESWL

+TUL

Others Total

ESWL only

TUL only

ESWL + TUL

No.

(%)

UOEH   urology

Chronological change of surgical management for upper urinary tract stones

Open surgery

TUL or PNL

ESWL(incl. combined)

% Surgical treatment

% No surgical treatment

UOEH   urology

Japanese guidelines for the management of stone diseases Dec, 2002, JUA

Renal stone(1)<20mm; ESWL(2)>20mm or Staghorn; PNL with ESWL

Ureter stone  (1) Proximal; ESWL     Option: (TUL, PNL)

(2) Middle; TUL or ESWL(3) Distal; <10mm; ESWL

    >10mm; TUL

UOEH   urology

UOEH   urology

Experience in our hospital

The UOEH urolithiasis guideline

Renal stones (1) 5 to 20mm; ESWL Option:(PNL or TUL) (2)20mm to 30mm ; ESWL with double-J stent Option:(PNL or TUL) (3)>30 mm; PNL (with ESWL) Option:(lithotomy)

Ureter stones   (A) Proximal; ESWL     Option:(TUL or PNL) (B) Middle; ESWL (C) Distal; (1) 5 to 10mm; ESWL (2)>10mm; TUL

UOEH   urology

UOEH hospital

Number of new patients in Urology servicein outpatient clinic in UOEH hospital

Around 10% is stone diseases

0

500

1000

1500

2000

2500

他疾患結石患者

year

OthersStones

UOEH   urology

UOEH hospital

Location of stones

050100150200250300350

膀胱結石尿管結石腎結石

year

BladderUreterKidney

UOEH   urology

UOEH hospital

UOEH   urology

Ureteral stone

2007 Guideline for the management of ureteral calculi  (EAU, AUA)

Stone Passage Rate (Meta analysis) Spontaneous passage <5mm; 68% >5mm, <10mm; 47%

Medical treatment to increase passage (MET) Nifedipine (Ca channel blocker); 9% (not significant) -blocker; 29%(significant) Tamsulosin (20% increase)> Nifedipine (significant)

No. of patients received surgical management

050100150200250300350

経過観察手術患者

year

UOEH   urology

No surgerySurgery

UOEH hospital

UOEH   urology

For all index patients Standard; Bacteriuria should be treated. (IV) Blind basket catheter should not be performed. (IV)

For ureteral stones <10mm Option; Observation with periodic evaluation. (1A) Standard; Should be counseled on the risks of MET. (IV)

For ureteral stones >10mm Standard; Must be informed about active treatment modality. (IV) Recommendation; SWL and URS first-line treatment (1A-IV) Routine stenting is not recommended (III) Option; Stenting following uncomplicated URS is optional (1A) Percutaneous antegrade ureteroscopy is first-line treatment in selected patients (III) ; impact large stoen in upper ureter, combination with renal stone removal, ureteral stone after urinary diversion, failure of retrograde ureteral access.

Index PatientNonpregnant adultUnilateral noncystine/nonuric acid radiopaque stoneNormal contralateral renal functionHealthy patient

2007 Guideline for the management of ureteral calculi  (EAU, AUA)

Surgical management

0

50

100

150

200

膀胱切石尿管切石腎盂切石膀胱砕石TULPNLESWL

year

UOEH   urology

UOEH hospital

VesicolithotomyUreterolithotomyPyelolithotomyVesicolithotripsy

UOEH   urology

Stone free rates for SWL and URS in the overall population

Overall population

Distal ureter Distal ureter <10mm Distal ureter >10mmMid ureter Mid ureter <10mm Mid ureter >10mmProximal ureter Proximal ureter <10mm Proximal ureter >10mm

SWL

74%86%74%73%84%76%82%90%68%

URS

94%97%93%86%91%78%81%80%79%

Statistics

significantsignificantsignificant

nsnsnsnsns

significant2007 Guideline for the management of ureteral calculi

  (EAU, AUA)

Results of TUL ( 2005 ~ 2007 )

Cases Stone free rate

15 11( 73 %)

9 5( 56 %)

24 22( 91.6 %)

U1

U2

U3

UOEH hospital

UOEH   urology

Conversion from ESWL to TUL

ESWL cases Conversion to TUL

82 7 (8.5%)

81 2 (2.4%)

60 4 (6.6%)

Total

2005

2006

2007

223 13 (5.8%)

UOEH hospital

UOEH   urology

Patient; 61y, FemalePresent illness: Recurrent UTI for 3 years & Lt hydronephrosis due to Lt ureter stone (U1)

Past history; Kaiser ope 2 times. Ope for Abdominal wall hernia

Complication; Obese Ope scar

A case of problem stone

UOEH   urology

22×12mm

DIP

CT

Impacted stone

UOEH   urology

Option of management (U1;Impacted stone)

ESWL; High failure rate to impacted stone

TUL; Difficulty of keeping optical view or push up to kidney

PNL; Damage of Lt kidney

Operation performed; Retroperitoneoscopic ureterolithotomy

Retroperitoneoscopic ureterolithotomy

N ×

×

12mm port

5mm port×

Lt ureter

Ureterotomy Stone

2 weeks after ope 3 months after ope

Retroperitoneal laparoscopipc ureterolithotomy is one of option forlong-term impacted stone.

UOEH   urology

Stone disease is infectious diseases?

UOEH   urology

UTI and urinary stone are closely related.

Urinary stone induces UTI.

UTI causes urinary stone.

All kind of human diseases is closely related with infection?

Cancer: Uterine cervical cancer;Human papilloma virus Liver cancer; Hepatitis virus C Gastric cancer; Helicobacter pyroli Renal cancer; Virus?

Arteriosclerosis, Myocardial infarction; Chlamydophyla pneumoniaeMany kinds of autoimmune diseases, Collagen diseases Benign prostatic hyperplasia etc, etc

Urinary stone is also infectious disease?UOEH   urology

UOEH   urology

Stone diseases are infectious diseases?

1. Urea splitting enzyme producing-microorganism; Struvite stone

2. Nanobacteria; Apatite stone

3. Oxalobacter formigenes; Prevent stone      formation due to diminish the      absorption and excretion of           oxalate

Urea splitting enzyme-producing bacteria causes struvite stone

UOEH   urology

Many kinds of ureasplitting enzyme-producing bacteria;cause complicatedUTI.

GNR

GPC

Mycoplasma

Fungi

Microorganism Almost all producing Sometimes producing

UOEH   urology

Urease –producing bacteria

While struvite stone is caused by UTI,

Apatite stone is also caused by infection?

UOEH   urology

UOEH   urology

NanobacteriaKajander & Ciftcioglu (Finnish researcher, PNAS 1998) -Putative cell-walled   microorganism -Low diameter; 0.2m -Apparent culture -Partially characterized Ribosomal RNA -Isolated from human and cow blood -Microscopic mineral structure (Ca, P) =Biomineralization -Not culturable in irradiated blood

Nanobacteria ;  Small, Gram negative Proteobacteria group Needle-shaped calcium apatite cell wall

UOEH   urology

Nanobacteria; an infectious cause for kidney stone formation ; Ciftcioglu et al; Kidney Int 1999

SEM;70/72 (97.2%) stones were Nanobacteria positive.

UOEH   urology

Nanobacteria; Controversial pathogens in nephrolithiasis and polycystic kidney disease.Kajander et al; Curr Opin Nephrol Hypertens 2001

Direct injection of nanobateria into kidney resulted in stone formation in rats and rabbits

UOEH   urology

Nanobac Announces peer reviewed publication verifying self-propagating calcifying nanoparticles as a unique entityCNPs hypothesized to resemble prions

CAL-DETOX; EDTA Nanobac Pharmaceuticals Inc.

UOEH   urology

UOEH   urology

Controversial issue

Cisar J. (NIH, FDA group ; PNAS   2000) -Found same structure in same      condition -rRNA=Phyllobacterium      mysinacearum; contamination -Resistant to almost all antimicrbials and sodium azide -Non sensitive to heat and powerful respiratory inhibitor

     Conclusion

Infection is quite interesting.UOEH   urology

Recommended